Is Melatonin Bad for You? What the Evidence Actually Says (2026 Guide)

Melatonin is the most popular sleep supplement in North America, and it's the most misunderstood. Walk into any pharmacy and you'll find shelves of 5 mg and 10 mg gummies, fast-dissolves, and time-release tablets — most of them dosed at 30 to 100 times what your body produces in a typical night. Sleep clinicians have been quietly waving people off them for years, but the message hasn't really landed with consumers.

Here's the short version of what the research says: melatonin isn't dangerous in the way melatonin-skeptic content often implies. The “it suppresses your growth hormone and ruins your recovery” story isn't well supported in the literature. But melatonin also isn't doing what most people think it's doing — and for active people who care about sleep as a recovery tool, it's almost always the wrong lever to pull.

This piece walks through what melatonin actually is, what the evidence says about nightly use, where it genuinely works, and what to use instead when your goal is the kind of sleep that powers muscle recovery — not just hours on a Whoop graph.

Endogenous nighttime melatonin levels in adults peak at concentrations that correspond to roughly 0.1 to 0.3 mg of supplemental melatonin — and even that's a generous estimate. A 0.3 mg dose taken in the morning is enough to push circulating melatonin into the normal nighttime range in a healthy adult.

Now compare that to what's on the shelf. Most over-the-counter products contain 3 to 10 mg per serving, and gummy products often stack toward the higher end. That's a 10x to 100x overshoot of what your body would ever produce on its own.

The supplement industry's quality control on melatonin is, charitably, not great. The most cited study on this — published in the Journal of Clinical Sleep Medicine in 2017 — analyzed 31 commercial melatonin products and found that the actual melatonin content ranged from 83% less to 478% more than what the label claimed. Lot-to-lot variability within the same brand reached 465%.

A 2023 JAMA study repeated the experiment with 25 melatonin gummies sold in the U.S. The results barely improved: 22 of the 25 products contained doses ranging from 74% to 247% of the label claim. One contained no melatonin at all. Another contained CBD that wasn't listed on the label.

The practical upshot: when you take a “5 mg” gummy, you might be taking 3.7 mg or you might be taking 12. There is no way to know without lab equipment.

The honest answer is more boring than either side of the internet wants it to be. Melatonin is not “bad for you” in the way some popular content frames it — there's no good evidence that nightly use causes serious harm in healthy adults. But the case for using it as a nightly sleep aid is also weak, and that's the more important point.

The American Academy of Sleep Medicine (AASM) — the largest professional body of sleep clinicians in North America — published clinical practice guidelines in 2017 that explicitly recommend against using melatonin for chronic insomnia in adults. Their position has been reaffirmed in subsequent statements: melatonin can be useful for specific circadian timing problems (jet lag, shift work, delayed sleep phase syndrome), but it shouldn't be the first or even fifth tool you reach for when you can't sleep at night.

The reason isn't safety. It's efficacy. In the trials AASM reviewed, melatonin produced an average reduction in time-to-fall-asleep of roughly 9 minutes versus placebo — a small effect, smaller than what's seen with most other sleep aids, and not enough to justify nightly use of a hormone supplement.

This is the cleanest way to summarize the medical position: it's not that doctors think melatonin is dangerous. It's that they don't think it works very well for the thing most people use it for.

Common side effects of melatonin are usually mild but worth naming honestly:

• Next-day grogginess and fogginess, especially at higher doses or when taken too late in the evening. The half-life of melatonin in the blood is short, but the downstream effects on alertness can persist into the morning.
• Realistic dreams or fragmented dreaming, which some people enjoy and others find disruptive.
• Headaches, mild gastrointestinal symptoms, and occasionally mood shifts — irritability or low mood in the morning.
• Reduced alertness for several hours after taking it, which is why most clinical sources recommend not driving within five hours of a dose.

These aren't dramatic, and they don't happen to everyone. But they're a reminder that melatonin is biologically active. It's affecting your hormonal system, not just nudging you toward sleep.

When you flood any hormone receptor with high doses of an agonist, the receptor adapts. Melatonin receptors (MT1 and MT2) appear to be no exception, though the human evidence here is more limited than the popular conversation suggests.

What we do know: pharmacologically high doses of melatonin (5–10 mg) saturate receptors well past what physiological doses would. There's reasonable mechanistic concern that prolonged high-dose use could blunt receptor sensitivity over time. This isn't the same as “addiction” or “physical dependency” — melatonin doesn't produce a withdrawal syndrome — but it's a plausible reason to avoid chronic high doses.

The more useful frame: if you're taking 10 mg every night, you're using a dose that's wildly out of proportion to what your physiology would ever produce, and you're getting most of your benefit (such as it is) from the placebo of a bedtime ritual. A much smaller dose, taken much less often, is closer to what the science supports.

Some content in the natural-health space — including, full transparency, earlier article Thirdzy has published— has framed melatonin as something that potentially suppresses growth hormone, disrupts testosterone, and impairs overnight recovery. But that framing isn't well supported.

The actual literature on melatonin and the GH axis in trained adults is mixed and surprisingly small. Several controlled trials in resistance-trained males have found that pre-workout melatonin increases, not decreases, the growth hormone response to exercise (likely by suppressing somatostatin, GH's main brake). A 2025 systematic review of melatonin in athletes concluded the evidence on performance and hormonal markers is genuinely inconclusive.

That doesn't mean melatonin is great for recovery. It means the case against melatonin shouldn't rest on a hormonal-suppression story that the evidence doesn't actually support. The real reason melatonin is the wrong tool for active people is simpler, and we'll get to it next.

Sleep, for an active person, isn't measured in hours. It's measured in what happens during those hours — specifically, in the depth and quality of slow-wave (deep) sleep, where most of your physical recovery actually occurs. This is when growth hormone is released in pulses, when muscle protein synthesis peaks, when glycogen stores get topped up, and when the central nervous system resets after training stress.

Here's the issue: melatonin doesn't reliably improve slow-wave sleep architecture. It can shorten the time it takes you to fall asleep by a few minutes, and at the right dose and timing it can shift your circadian phase. Neither of those is the bottleneck for most people who train.

When an athlete or active person says “I'm not sleeping well,” what they usually mean is one of three things:

1. My nervous system is too activated to wind down (high stress, late training, late screen time, caffeine still on board).
2. My deep sleep feels shallow (low HRV in the morning, waking up unrefreshed despite full hours).
3. I'm waking up at 3 a.m. and can't get back down (often a cortisol/blood-sugar issue, sometimes alcohol-related).

None of those are problems melatonin is designed to solve. It addresses sleep timing — which is rarely the actual issue if you keep a reasonably consistent schedule.

The more useful interventions are the ones that target the underlying mechanisms: nervous system downregulation, deeper sleep architecture, and overnight tissue repair. That's the foundation of the Active Sleep Protocol, which approaches sleep as an active recovery process rather than a passive shutdown.

To be fair: there are situations where melatonin is genuinely useful, and pretending otherwise would be selling people short. The cases are narrower than the supplement industry implies, but they're real.

Jet lag, especially eastward travel across three or more time zones, is the strongest evidence-based use case. The Cochrane review on melatonin and jet lag is one of the most positive reviews of any sleep intervention in the database. The protocol matters: a small dose (0.5–3 mg) taken at the local destination bedtime for the first few nights, not before the flight.

Shift work — particularly rotating shifts or sustained night shifts — is a second case where strategically timed melatonin can help anchor the circadian system to a non-standard schedule.

Delayed Sleep-Wake Phase Disorder (the diagnosable version of “I just can't fall asleep before 3 a.m. no matter what”) responds to small doses of melatonin taken several hours before the desired bedtime. This is a true circadian timing problem — exactly what melatonin was designed to fix.

In all three cases, the dose is small, the use is short-term or strategic rather than nightly, and the goal is to shift timing rather than to “knock yourself out.” That's melatonin used correctly.

What's missing from this list is what most people are actually using melatonin for: chronic difficulty falling asleep at a normal bedtime, after a normal day, on a stable schedule. That use case has the weakest evidence base, and it's where the medical consensus most clearly says: probably not.

A few groups should be more careful with melatonin than the average adult:

• Children and teens. Pediatric melatonin use has exploded — calls to U.S. poison control centers for pediatric melatonin ingestion increased more than 500% from 2012 to 2021. Most cases are mild, but melatonin's interaction with developing endocrine systems isn't well studied, and the long-term effects of chronic use during puberty are unknown.
• Pregnant or breastfeeding individuals, where the evidence base is essentially non-existent and the precautionary principle applies.
• People on antidepressants, anti-anxiety medications, or blood pressure medications, particularly anything that affects serotonin pathways. Melatonin can interact with several of these.
• People with autoimmune conditions, where melatonin's modest immune-modulating effects haven't been adequately studied.
• Anyone who needs to drive or operate equipment within five hours of taking it, per Mayo Clinic guidance.

For most healthy adults, occasional short-term use isn't a problem. It's the nightly, indefinite, high-dose pattern that's worth re-examining.

If your goal is sleep that supports training, recovery, and steady daytime energy, the leverage is mostly upstream of any supplement.

Light exposure. Get bright light — ideally sunlight — within an hour of waking. This is the single biggest input to your circadian system, and your evening melatonin production is downstream of it. In the evening, dim your lights aggressively in the last 90 minutes before bed.

Schedule consistency. A regular sleep and wake time, ±30 minutes, even on weekends. Your body produces melatonin on a schedule it learns from your behavior. Keep the schedule stable and the hormone takes care of itself.

Temperature. A cool sleep environment (around 18°C / 65°F) supports the core body temperature drop that initiates and maintains deep sleep.

Caffeine and alcohol timing. Caffeine has a half-life of around 5–7 hours. Alcohol fragments deep sleep even at moderate doses. Both are bigger drivers of poor sleep in active adults than most people want to admit.

Training timing. High-intensity training within 2–3 hours of bed elevates cortisol and core temperature in ways that interfere with sleep onset for some people. If your sleep is fragile, move it earlier.

Once the foundations are in place, a few supplements have stronger evidence and a better risk profile than melatonin for nightly use:

• Magnesium (especially bisglycinate) supports nervous system downregulation, helps with muscle relaxation, and is one of the most consistently deficient minerals in active populations. Unlike melatonin, magnesium isn't a hormone — it's a cofactor your body needs for countless biological processes.
• Glycine (often delivered through hydrolyzed collagen) supports the core body temperature drop at sleep onset and has small but real evidence for improved sleep quality and next-day alertness.
• L-theanine and GABA support the nervous-system wind-down that's often the actual bottleneck for people who can't fall asleep despite being tired.

These work with your circadian system rather than overriding it. They don't displace endogenous hormone production. And critically, none of them are doing what melatonin does — which is the point.

Thirdzy's formula is built around this model. The Rest & Recover collagen formula combines magnesium bisglycinate, hydrolyzed collagen (a substantial dose of glycine), GABA, and L-theanine — designed for nightly use without melatonin, and built specifically for active adults whose sleep needs to do recovery work, not just clock hours.

If you've been relying on melatonin and want to taper off, the practical move is to start the foundations (light, schedule, temperature, caffeine timing) two weeks before you stop, then add a melatonin-free formula in place of the melatonin gummy. Most people find the transition easier than they expect — partly because the melatonin wasn't doing as much as they thought.

Melatonin isn't dangerous, but it's the wrong tool for what most people use it for. It's a chronobiotic — a circadian timing signal — being sold and used as a sleep aid, often at doses 10 to 100 times what your body produces, in products whose label accuracy is unreliable.

For specific use cases (jet lag, shift work, true delayed sleep phase disorder), it works. For chronic nightly use to fall asleep at a normal bedtime, the evidence is weak and the medical consensus is to look elsewhere.

For active people in particular — where sleep isn't just “hours unconscious” but a recovery window with specific physiological requirements — the real leverage is in supporting the systems your body actually uses to produce deep, restorative sleep. Light. Schedule. Temperature. Magnesium. Glycine. The boring fundamentals, applied consistently.

That's the model Thirdzy is built around, and it's why our formulas are melatonin-free by design. Not because melatonin is inherently bad — but because there's something more useful you could be taking.

It's not dangerous for most healthy adults to take melatonin nightly, but it's also not what most sleep clinicians would recommend. The American Academy of Sleep Medicine specifically recommends against melatonin as a treatment for chronic insomnia in adults — not because it's harmful, but because the evidence for its effectiveness is weak (a roughly 9-minute reduction in sleep onset versus placebo, on average). Nightly high doses also carry plausible concerns around receptor desensitization over time, even if true physical dependency hasn't been demonstrated.

Not really. Melatonin shortens the time it takes to fall asleep by a small amount (around 9 minutes versus placebo in clinical studies) and helps shift circadian timing, but it doesn't reliably improve slow-wave (deep) sleep architecture — which is the sleep stage that matters most for physical recovery. If your goal is deeper, more restorative sleep, magnesium, glycine, and behavioral inputs like consistent timing and light exposure have stronger evidence.

The evidence here is more mixed than the natural-health internet implies. Some controlled trials in resistance-trained males have actually shown that melatonin increases the growth hormone response to exercise rather than suppressing it. A 2025 systematic review concluded the evidence on melatonin's effects on athletic performance and hormonal markers is genuinely inconclusive. The case against melatonin for active people isn't about hormone disruption — it's that melatonin doesn't address the deep-sleep recovery window that athletes actually need.

True physical dependency hasn't been demonstrated — melatonin doesn't produce a classical withdrawal syndrome the way benzodiazepines or alcohol do. The more realistic concerns are receptor desensitization at chronic high doses, possible blunting of endogenous melatonin production over time (less well studied), and the psychological habit of needing a pill to fall asleep. People often find they sleep worse for 2–3 nights after stopping, then return to baseline.

Most over-the-counter products contain 3–10 mg per serving, while your body produces only about 0.1–0.3 mg of endogenous melatonin nightly. From a physiological standpoint, anything above 1 mg is already well into supraphysiological territory, and most clinical research uses doses in the 0.3–3 mg range. Doses of 5–10 mg aren't dangerous in the short term but offer no additional sleep benefit and increase the likelihood of next-day grogginess and disturbing dreams.

The American Academy of Sleep Medicine's 2017 clinical practice guideline specifically recommends against melatonin for sleep onset or sleep maintenance insomnia in adults, citing weak evidence for efficacy. The recommendation is “weak” in technical terms but consistent: clinicians prefer cognitive behavioral therapy for insomnia (CBT-I) as first-line, followed by FDA-approved sleep medications when indicated. Melatonin is reserved for circadian timing problems like jet lag and shift work, where its evidence is much stronger.

Three cases have solid evidence: jet lag (especially eastward travel across 3+ time zones), shift work for people working overnight or rotating schedules, and delayed sleep-wake phase disorder (a circadian disorder where someone genuinely can't fall asleep before 2–3 a.m. on any schedule). In all three cases, the dose is small (0.5–3 mg), the use is strategic rather than nightly, and the goal is to shift circadian timing rather than to sedate.

For nightly use, magnesium glycinate (200–300 mg elemental), glycine (often delivered through hydrolyzed collagen), L-theanine, and GABA have better evidence-to-risk profiles than melatonin and don't override your endogenous hormonal system. These ingredients support nervous-system downregulation and deeper sleep architecture rather than just signaling “it's bedtime.” They're the basis of Thirdzy's melatonin-free formulas, designed specifically for active adults using sleep as a recovery tool.

Yes, particularly at doses above 1–3 mg or when taken too late in the evening. Although melatonin's blood half-life is short, downstream effects on alertness can persist into the morning for some people. If you experience consistent morning fogginess from melatonin, the most common fix is reducing the dose dramatically (try 0.3–0.5 mg) or switching to a non-hormonal sleep formula.

There's no strong evidence that long-term use causes serious harm in healthy adults, but there's also limited high-quality long-term safety data, and the sustained-overshoot of physiological levels at typical OTC doses is biologically unusual. Most clinical sources are comfortable with short-term use (under 3 months) and recommend caution beyond that — particularly in adolescents, pregnant individuals, and people on medications affecting serotonin or blood pressure.